Cargando…

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value

BACKGROUND: Immunohistochemical assessment of proliferation may provide additional prognostic information in early breast cancer. However, due to a lack of methodological standards proliferation markers are still not routinely used for determining therapy. Even for Ki67, one of the most widely-studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Shalaka, Watkins, Johnathan, Gazinska, Patrycja, Brown, John P., Gillett, Cheryl E., Grigoriadis, Anita, Pinder, Sarah E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513675/ https://www.ncbi.nlm.nih.gov/pubmed/26205655 http://dx.doi.org/10.1186/s12885-015-1531-3

Ejemplares similares

Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
por: Torres-Rendon, A, et al.
Publicado: (2009)

Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues
por: Xing, Yan, et al.
Publicado: (2017)

Comparative Immunohistochemical Analysis of Ochratoxin A Tumourigenesis in Rats and Urinary Tract Carcinoma in Humans; Mechanistic Significance of p-S6 Ribosomal Protein Expression
por: Gazinska, Patrycja, et al.
Publicado: (2012)

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
por: RIBEIRO, MARCELO BARBOSA, et al.
Publicado: (2023)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
por: Yang, Jun, et al.
Publicado: (2006)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
por: Güler, Nurhan, et al.
Publicado: (2012)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
por: Rezazadeh, Fahimeh, et al.
Publicado: (2017)

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival
por: Gracio, Filipe, et al.
Publicado: (2017)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas
por: Aman, Nguiessan Alphonse, et al.
Publicado: (2019)

Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis
por: Hammad, Huda M., et al.
Publicado: (2020)

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers
por: Grigoriadis, Anita, et al.
Publicado: (2018)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
por: Pinkowska, Agnieszka, et al.
Publicado: (2021)

Spotlight on Geminin
por: DePamphilis, Melvin L
Publicado: (2011)

Immunohistochemical analysis of Ki-67 in dental follicle of asymptomatic impacted third molars
por: Kucukkolbasi, Hasan, et al.
Publicado: (2014)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
por: Mehdi, Muhammad Zain, et al.
Publicado: (2016)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
por: Vivatvakin, Sarocha, et al.
Publicado: (2021)

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
por: de Rinaldis, Emanuele, et al.
Publicado: (2013)

Immunohistochemical detection of laminin-1 and Ki-67 in radicular cysts and keratocystic odontogenic tumors
por: Ayoub, Mohamed S, et al.
Publicado: (2011)

Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts
por: Shi, Peng, et al.
Publicado: (2016)

An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions
por: Dash, Kailash C, et al.
Publicado: (2020)

Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
por: Ramezani, Mazaher, et al.
Publicado: (2019)

An Immunohistochemical Study on Ki-67 Expression in Squamous Cell Carcinomas of Cervix With Clinicopathological Correlation
por: R, Devaki Priyanka, et al.
Publicado: (2023)

Immunohistochemical study of the expression of alpha-smooth muscle actin and the proliferation marker Ki-67 of glomerulonephritis.
por: Kim, O.
Publicado: (2001)

Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma
por: Leblebici, Cem, et al.
Publicado: (2017)

Analysis of Ki-67 Expression in Oral Premalignant Lesions and Normal Oral Mucosa: An Immunohistochemical Study
por: Beevi, Basheer H., et al.
Publicado: (2019)

Generative Adversarial Domain Adaptation for Nucleus Quantification in Images of Tissue Immunohistochemically Stained for Ki-67
por: Zhang, Xuhong, et al.
Publicado: (2020)

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients
por: Priambada, Dody, et al.
Publicado: (2023)

Geminin halts DNA synthesis
por: LeBrasseur, Nicole
Publicado: (2004)

Geminin Is Required for the Maintenance of Pluripotency
por: Tabrizi, Golnaz A., et al.
Publicado: (2013)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of (18)F-deoxyglucose levels on positron emission tomography for breast cancers
por: Nishimukai, Arisa, et al.
Publicado: (2017)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions(,)
por: Choy, Bonnie, et al.
Publicado: (2016)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

The relation of pericoronal third molar follicle dimension and bcl-2/ki-67 expression: An immunohistochemical study
por: Razavi, Seyed Mohammad, et al.
Publicado: (2012)

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma
por: Gonzalez-Sistal, Angel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kn00jt7fugek11v9bt9kalii3v